Key market Insights
§ Currently,
over 100 firms claim to offer a variety of novel digital manufacturing solutions in order to cater to the rising demand
for biopharmaceuticals
§ 140+ platforms, based on PAT, DAS, MES, digital twins
and other such technologies, are being offered for digitalization of the
biologic production process
§ Over
85% of the process analytical technologies are capable of offering process
automation and bioprocess optimization and controls; majority of these
platforms support manufacturing of proteins and antibodies
§ Data
analysis software offer a wide spectrum of technical competencies, including
process intelligence and data integration; predominantly, these platforms are
compatible with artificial intelligence-based programs
§ Leveraging
their expertise, ~80% players are offering cloud-based MES solutions that can
be integrated with numerous types of software to carry out production tracking,
performance analysis and data integration functions
§ The
developer landscape is dominated by the presence of established players; asset
/ process management emerged as the prominent application areas for digital
twin technologies
§ In
pursuit of gaining a competitive edge, digital
biomanufacturingproviders are upgrading their existing software capabilities and enhancing
their biologic focused technology portfolios
§ The
growing preference for digitalization of bioprocessing is evident
from the rise in partnership activity; it is worth highlighting that more than 80% of the deals were forged in the last
three years
§ Being
a relatively concentrated market, players are focused on developing unique
selling propositions for their technology platforms and become strategic
partners for biologic developers
§ The
adoption of digital biomanufacturing solutions has increased considerably in
recent years; white spaces in this domain present significant growth
opportunities for innovators
§ Fundamental
advancements in the field of smart biomanufacturing will promote process
robustness and product quality; this will inevitably culminate in accelerated
growth of the market
§ Driven
by the continuous technological innovations, this domain is
anticipated to witness steady growth; technologies focused on digital twins are
expected to gain significant traction with an annualized growth of 26%
§ The projected opportunity for digital bioprocessing
platforms is expected to be well distributed across different types of
biologics and key geographical regions
Table of Contents
1. PREFACE
1.1. Introduction
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Chapter Overview
3.2. Overview of Digital manufacturingin Healthcare
3.3. Emerging Technologies that Support Digital
Biomanufacturing
3.4. Challenges Associated with the Adoption of
Digital Biomanufacturing
3.5. Future Perspectives
4. MARKERT LANDSCAPE
4.1. Chapter Overview
4.2. List of Process Analytical Technology
(PAT) Providers
4.3. List of Data Analysis Software (DAS)
Providers
4.4. List of Manufacturing Execution Systems
(MES) Providers
4.5. List of Digital Twins Providers
5. TECHNOLOGY COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Assumptions and Key Parameters
5.3. Methodology
5.4. Technology Competitiveness Analysis:
Process Analytical Technologies
5.5. Technology Competitiveness Analysis: Data
Analysis Software
5.6. Technology Competitiveness Analysis:
anufacturing Execution Systems
5.7. Technology Competitiveness Analysis:
Digital Twins
6. COMPANY PROFILES
6.1. Chapter Overview
6.2. AspenTech
6.3. FUJIFILM Diosynth Biotechnologies
6.4. Merck
6.5. Thermo Fisher Scientific
6.6. Bioreactors.net
6.7. Sartorius
6.8. Dassault Systèmes
6.9. GE Healthcare
6.10. Körber
7. BENCHMARKING ANALYSIS
7.1. Chapter Overview
7.2. Methodology and Key Assumptions
7.3. Competitive Benchmarking by Company Size
and Region
7.4.
Competitive Benchmarking: Pockets of
Innovation and White Spaces
8. PARTNERSHIPS AND COLLABORATIONS
8.1. Chapter Overview
8.2. Partnership Models
8.3. Digital Biomanufacturing: List of
Partnerships and Collaborations
9. MARKET CONCENTRATION ANALYSIS
9.1. Chapter Overview
9.2. Assumptions and Key Parameters
9.3. Methodology
9.4. Market Concertation Analysis: Top Digital
Biomanufacturing Providers
10. INDUSTRY LIFECYCLE ANALYSIS
10.1. Chapter Overview
10.2. Industry Lifecycle Analysis
10.3. Digital Biomanufacturing: Historical
Timeline of Key Events
10.4. Digital Biomanufacturing: Start-up Activity
10.5. Digital Biomanufacturing: Established
Players Activity
10.6. Digital Biomanufacturing: Partnership and
Collaboration Trends
10.7. Digital Biomanufacturing: Funding and
Investments Trends
10.8.
Current Barriers to Wider Adoption of
Digitalization in Biomanufacturing
10.9.
Future Outlook of Digital Biomanufacturing
10.10. Industry Lifecycle Analysis: Digital
Biomanufacturing
11. MARKET FORECAST AND OPPORTUNITY ANALYSIS
11.1. Chapter Overview
11.2. Forecast Methodology and Key Assumptions
11.3. Global Digital Biomanufacturing Market,
2023-2035
11.4. Digital manufacturing Market:
Analysis by Type of Technology
11.5.
Digital Biomanufacturing Market:
Analysis by Type of Deployment Options
11.6.
Digital Biomanufacturing Market:
Analysis by Type(s) of Biologic(s) Manufactured
11.7.
Digital Biomanufacturing Market:
Analysis by Geography
12.
CONCLUDING REMARKS
13. APPENDIX I: TABULATED DATA
14. APPENDIX II: LIST OF COMPANIES AND
ORGANIZATIONS
To
view more details on this report, click on the link
https://www.rootsanalysis.com/reports/digital-biomanufacturing-market.html
News article
Global Digital Therapeutics Market
Learn
from experts: do you know about these emerging
industry trends?
Cell Therapy –
The Revolutionary Therapeutic Modality: All Set To Obliterate Oncological
Disorders
4D Bioprinting Market:
Key Trends
About Roots Analysis
Roots Analysis is a global leader in the
pharma / biotech market research. Having worked with over 750 clients
worldwide, including Fortune 500 companies, start-ups, academia, venture
capitalists and strategic investors for more than a decade, we offer a highly
analytical / data-driven perspective to a network of over 450,000 senior
industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415